PT1625135E - Composição de fondaparinux sódico de pureza elevada - Google Patents

Composição de fondaparinux sódico de pureza elevada Download PDF

Info

Publication number
PT1625135E
PT1625135E PT04710418T PT04710418T PT1625135E PT 1625135 E PT1625135 E PT 1625135E PT 04710418 T PT04710418 T PT 04710418T PT 04710418 T PT04710418 T PT 04710418T PT 1625135 E PT1625135 E PT 1625135E
Authority
PT
Portugal
Prior art keywords
high purity
fondaparinux sodium
sodium composition
composition
fondaparinux
Prior art date
Application number
PT04710418T
Other languages
English (en)
Inventor
Henricus Cornelis Joz Claassen
Jean-Francois Branellec
Christian Morello
Pierre Potier
Patrick Trouilleux
Petrus Marcus F M Bastiaansen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT1625135E publication Critical patent/PT1625135E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT04710418T 2003-02-27 2004-02-12 Composição de fondaparinux sódico de pureza elevada PT1625135E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37526803A 2003-02-27 2003-02-27

Publications (1)

Publication Number Publication Date
PT1625135E true PT1625135E (pt) 2009-07-10

Family

ID=32961215

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04710418T PT1625135E (pt) 2003-02-27 2004-02-12 Composição de fondaparinux sódico de pureza elevada

Country Status (14)

Country Link
US (1) US20050020536A1 (pt)
EP (1) EP1625135B1 (pt)
JP (1) JP4594298B2 (pt)
AR (1) AR044200A1 (pt)
AT (1) ATE427953T1 (pt)
CY (1) CY1109168T1 (pt)
DE (1) DE602004020459D1 (pt)
DK (1) DK1625135T3 (pt)
ES (1) ES2322464T3 (pt)
HK (1) HK1087719A1 (pt)
PT (1) PT1625135E (pt)
SI (1) SI1625135T1 (pt)
TW (1) TWI335224B (pt)
WO (1) WO2004078105A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
JP2008541231A (ja) * 2005-05-05 2008-11-20 アーキペラゴ ホールディングス インコーポレイテッド 反内在化注文の変成装置
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US8277143B2 (en) * 2009-05-12 2012-10-02 RSA Protective Technology, LLC Surface mount vehicle anti-ram security systems
CA2777099C (en) 2009-07-31 2018-03-27 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
US20130005954A1 (en) * 2011-06-28 2013-01-03 Apicore, Llc Process for preparing heparinoids and intermediates useful in the synthesis thereof
CN102659859B (zh) * 2012-04-11 2014-12-10 苏州纳微科技有限公司 单分散聚甲基丙烯酸酯离子交换层析介质在磺达肝癸钠柱层析纯化中的应用
CN103570774B (zh) * 2012-08-07 2017-08-25 博瑞生物医药（苏州）股份有限公司 一种戊糖化合物的纯化方法
KR102112119B1 (ko) 2012-10-22 2020-05-19 사이덱스 파마슈티칼스, 인크. 알킬화된 시클로덱스트린 조성물 및 이의 제조 및 사용 방법
CN103864862B (zh) * 2012-12-14 2017-10-17 博瑞生物医药（苏州）股份有限公司 一种戊糖化合物的纯化方法
KR20160036606A (ko) * 2013-07-25 2016-04-04 시노팜 타이완 리미티드 폰다파리눅스 소듐의 제조 방법
US9346844B2 (en) 2013-07-25 2016-05-24 Scinopharm Taiwan, Ltd. Process for the production of fondaparinux sodium
US10072039B2 (en) 2013-07-25 2018-09-11 Scinopharm Taiwan, Ltd. Process for the production of Fondaparinux sodium
CN103992364B (zh) * 2014-03-25 2016-08-10 南京天翔医药科技有限公司 一种磺达肝癸钠的分离提取方法
CN103965269B (zh) * 2014-04-16 2018-05-04 杭州华东医药集团新药研究院有限公司 低水分高纯度的磺达肝癸钠及其制备方法
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105037452B (zh) * 2015-06-19 2018-10-09 天津红日药业股份有限公司 一种快速制备高纯度磺达肝癸钠的精制方法
CN104910217B (zh) * 2015-06-19 2018-04-17 天津红日药业股份有限公司 用于磺达肝癸钠质量控制的参比化合物
CN107501359B (zh) * 2017-08-24 2020-07-31 深圳市海滨制药有限公司 一种磺达肝癸钠杂质化合物及其制备方法与应用
CN114478663B (zh) * 2020-11-12 2023-12-01 杭州中美华东制药有限公司 一种磺达肝癸钠杂质的制备方法
CN114591379A (zh) * 2021-12-30 2022-06-07 淮北师范大学 一种磺达肝癸钠甲酰化杂质的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE664087A (pt) * 1956-03-29
US4025357A (en) * 1975-04-14 1977-05-24 A. E. Staley Manufacturing Company Ion exchange enrichment of impure dextrose solutions
JPS5577896A (en) * 1978-12-07 1980-06-12 Meiji Seika Kaisha Ltd Preparation of high-purity maltose
FR2456116A1 (fr) * 1979-05-11 1980-12-05 Sarget Lab Nouvelle saponine triterpenique derivee de la caulophyllogenine et ses applications therapeutiques
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4502890A (en) * 1981-03-02 1985-03-05 Calgon Carbon Corporation Purification of sugar liquors with activated carbon
DE3118588C2 (de) * 1981-05-11 1983-07-07 Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung
JPS5899497A (ja) * 1981-11-27 1983-06-13 Snow Brand Milk Prod Co Ltd 新規なオリゴ糖、その製造法及びビフイドバクテリウム菌の増殖促進剤
JPS60102196A (ja) * 1983-11-07 1985-06-06 Daicel Chem Ind Ltd 粗グリコシドの精製処理方法
US4686102A (en) * 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
JPS61118336A (ja) * 1984-11-13 1986-06-05 Yonezawa Kagaku Kogyo Kk ペンタクロルフエノ−ル及びその誘導体の精製法
JPH0673442B2 (ja) * 1986-03-13 1994-09-21 明治製菓株式会社 食品の老化防止方法
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
JPS6398395A (ja) * 1986-10-16 1988-04-28 Katakura Chitsukarin Kk キトサンオリゴ糖の製造法
US5756721A (en) * 1991-01-16 1998-05-26 National Starch And Chemical Investment Holding Corporation Purification of polysaccharides
US5569756A (en) * 1995-03-21 1996-10-29 American Maize-Products Company Purification of chemically modified cyclodextrins
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
KR20020084058A (ko) * 1999-08-30 2002-11-04 모씨 앤드 기솔피 오버시즈 소시에떼아노님 활성탄층을 이용한 나프탈렌 디카르복실산의 디칼륨염의분리 방법

Also Published As

Publication number Publication date
JP4594298B2 (ja) 2010-12-08
JP2006519246A (ja) 2006-08-24
SI1625135T1 (sl) 2009-08-31
DK1625135T3 (da) 2009-06-22
US20050020536A1 (en) 2005-01-27
EP1625135B1 (fr) 2009-04-08
AR044200A1 (es) 2005-09-07
CY1109168T1 (el) 2014-07-02
TWI335224B (en) 2011-01-01
ATE427953T1 (de) 2009-04-15
WO2004078105A3 (fr) 2004-10-28
DE602004020459D1 (de) 2009-05-20
TW200501965A (en) 2005-01-16
EP1625135A2 (fr) 2006-02-15
WO2004078105A2 (fr) 2004-09-16
HK1087719A1 (en) 2006-10-20
ES2322464T3 (es) 2009-06-22

Similar Documents

Publication Publication Date Title
HK1087719A1 (en) Fondaparinux sodium composition of high purity
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
HK1085380A1 (en) Immunogenic composition
HK1074846A1 (en) Immunogenic compositions
PL2181988T3 (pl) Kompozycje farmaceutyczne oparte na Krystalicznej Postaci I 5-azacytydyny
AU2003259290A8 (en) Glass compositions
EP1633357A4 (en) MONTELUKAST SODIUM POLYMORPHIC SHAPE
EP1501509A4 (en) THIAZOLIDINE-DIONE AND OXAZOLIDINE-DIONE WITH ARYL-ARYL-ARYLON SUBSTITUTION USEFUL AS BLOCKERS OF SODIUM CHANNELS
PL372880A1 (en) Crystalline parecoxib sodium
AU2003224781A1 (en) Crystalline forms of rabeprazole sodium
PL372655A1 (en) Compositions of pentafluoropropane
IL161560A0 (en) Anthelmintic compositions containing milbemycin derivatives
AU2003237598A8 (en) Process for the preparation of highly pure rabeprazole sodium salt
GB2413764B (en) Anthelmintic composition
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
HUP0400080A2 (hu) Eljárás nátrium-3-hidroxi-3-metil-butirátot tartalmazó, szilárd halmazállapotú készítmények előállítására
AU2003298725A8 (en) Preparation of metallotexaphyrins
AU2003250828A8 (en) Immunogenic compositions
AU2003238669A1 (en) Novel crystalline forms of parecoxib sodium
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
PL356729A1 (en) Method of manufacture of sodium percarbonate
PL364145A1 (en) Method for manufacture of sodium percarbonate
TW576451U (en) Linking structure of slope protection blocks
TW542458U (en) Combining structure of connector